GtoPdb is requesting financial support from commercial users. Please see our sustainability page for more information.
References |
1. Yang H, Wang P, Li X, Wei Q, Yu J, Wu X, Huang Y, Li R, Du W, Zeng S et al.. (2024)
A randomised, double-blind, placebo-controlled, first-in-human phase I study to characterise the safety, pharmacokinetics and immunogenicity of 9MW1411 in healthy Chinese subjects. Int J Antimicrob Agents, 63 (2): 107075. [PMID:38157918] |